Decreased neurocognitive progression with Motexafin Gadolinium (MGd) plus Whole Brain Radiation Therapy (WBRT) in non-small cell lung cancer (NSCLC) patients with brain metastases: pooled analysis of two randomized phase 3 trials Conference

Mehta, Minesh, Leibenhaut, Mark, Suh, John et al. (2007). Decreased neurocognitive progression with Motexafin Gadolinium (MGd) plus Whole Brain Radiation Therapy (WBRT) in non-small cell lung cancer (NSCLC) patients with brain metastases: pooled analysis of two randomized phase 3 trials . JOURNAL OF THORACIC ONCOLOGY, 2(8), S335-S336. 10.1097/01.JTO.0000283145.98917.5e

Open Access Industry Collaboration

cited authors

  • Mehta, Minesh; Leibenhaut, Mark; Suh, John; Meyers, Christine; Renschler, Markus F; Smith, Jennifer; Phan, See C

authors

publication date

  • August 1, 2007

webpage

published in

keywords

  • Life Sciences & Biomedicine
  • Oncology
  • Respiratory System
  • Science & Technology

Digital Object Identifier (DOI)

publisher

  • LIPPINCOTT WILLIAMS & WILKINS

start page

  • S335

end page

  • S336

volume

  • 2

issue

  • 8